Raymond James & Associates Atrion Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$381.09 - $495.99 $19,435 - $25,295	-51 Reduced 0.72%	7,072 $3.2 Million
Q1 2024 Apr 22, 2024	BUY	$308.3 - $463.55 $228,142 - $343,027	740 Added 11.59%	7,123 $3.3 Million
Q4 2023 Jan 16, 2024	SELL	$289.29 - $409.7 $188,038 - $266,305	-650 Reduced 9.24%	6,383 $2.42 Million
Q3 2023 Oct 24, 2023	SELL	$401.2 - $581.79 $101,102 - $146,611	-252 Reduced 3.46%	7,033 $2.91 Million
Q2 2023 Jul 25, 2023	BUY	$500.0 - $659.0 $38,000 - $50,084	76 Added 1.05%	7,285 $4.12 Million
Q1 2023 Apr 14, 2023	BUY	$565.0 - $694.87 $364,990 - $448,886	646 Added 9.84%	7,209 $4.53 Million
Q4 2022 Feb 08, 2023	SELL	$551.1 - $688.5 $331,762 - $414,477	-602 Reduced 8.4%	6,563 $3.67 Million
Q3 2022 Oct 25, 2022	BUY	$545.43 - $680.3 $3.41 Million - $4.25 Million	6,254 Added 686.5%	7,165 $4.05 Million
Q2 2022 Aug 12, 2022	BUY	$605.0 - $763.25 $268,015 - $338,119	443 Added 94.66%	911 $573,000
Q1 2022 May 11, 2022	SELL	$601.4 - $763.0 $30,070 - $38,150	-50 Reduced 9.65%	468 $334,000
Q4 2021 Feb 08, 2022	BUY	$650.15 - $802.0 $124,178 - $153,182	191 Added 58.41%	518 $365,000
Q3 2021 Nov 02, 2021	SELL	$594.24 - $758.0 $14,856 - $18,950	-25 Reduced 7.1%	327 $228,000
Q2 2021 Aug 11, 2021	SELL	$582.88 - $670.99 $6,411 - $7,380	-11 Reduced 3.03%	352 $219,000
Q1 2021 May 14, 2021	BUY	$619.2 - $736.0 $12,384 - $14,720	20 Added 5.83%	363 $233,000
Q4 2020 Feb 12, 2021	SELL	$576.6 - $672.2 $1.36 Million - $1.59 Million	-2,359 Reduced 87.31%	343 $220,000
Q3 2020 Nov 04, 2020	BUY	$620.1 - $689.89 $80,613 - $89,685	130 Added 5.05%	2,702 $1.7 Million
Q2 2020 Jul 28, 2020	BUY	$610.05 - $713.9 $312,955 - $366,230	513 Added 24.92%	2,572 $1.64 Million
Q1 2020 Apr 21, 2020	BUY	$615.5 - $751.4 $27,697 - $33,813	45 Added 2.23%	2,059 $1.34 Million
Q4 2019 Feb 12, 2020	BUY	$688.5 - $846.15 $117,733 - $144,691	171 Added 9.28%	2,014 $1.52 Million
Q3 2019 Nov 07, 2019	BUY	$722.04 - $840.0 $18,773 - $21,840	26 Added 1.43%	1,843 $1.44 Million
Q2 2019 Aug 06, 2019	BUY	$837.83 - $927.0 $52,783 - $58,401	63 Added 3.59%	1,817 $1.55 Million
Q4 2018 Feb 11, 2019	SELL	$667.94 - $785.7 $54,771 - $64,427	-82 Reduced 4.47%	1,754 $1.3 Million
Q3 2018 Nov 14, 2018	BUY	$602.8 - $699.6 $100,667 - $116,833	167 Added 10.01%	1,836 $1.28 Million
Q2 2018 Aug 14, 2018	SELL	$568.25 - $635.8 $19,888 - $22,253	-35 Reduced 2.05%	1,669 $1 Million
Q1 2018 May 14, 2018	BUY	$526.8 - $633.85 $211,246 - $254,173	401 Added 30.78%	1,704 $1.08 Million
Q4 2017 Feb 14, 2018	BUY	$620.6 - $689.35 $15,515 - $17,233	25 Added 1.96%	1,303 $824,000
Q3 2017 Nov 13, 2017	SELL	$608.7 - $680.0 $31,652 - $35,360	-52 Reduced 3.91%	1,278 $861,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,330	1,330 $857,000

Others Institutions Holding ATRI

# of Institutions

Shares Held

114K

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account